Study Group: DexCom Continuous Glucose Monitoring Systems Users

Council Members in this Study Group: 25

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Kelly Close, President, Close ConcernsKelly Close

President
Close Concerns
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Kelly Close is President of Close Concerns, a healthcare information firm focused exclusively on diabetes and obesity. She has over 15 years of experience at the intersection of finance and healthcare. Ms. Close specializes in financial analysis within...

24 news post(s)
6 event(s)
Ronald Innerfield, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.Ronald Innerfield

Vice President of Clinical Affairs
Evidence Based Medicine, Inc.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Ronald Innerfield, MD, FACE, is Chief of Clinical Trials and Epidemiology, Emeritus, at the Dorothy Bullock Memorial National Diabetes Center. He is also Vice President of Clinical Affairs of Evidence Based Medicine, a site management organization (SMO)...

1 news post(s)
3 event(s)
Michael Dempsey, Medical Director, Johns Hopkins Diabetes Center at Suburban HospitalMichael Dempsey

Medical Director
Johns Hopkins Diabetes Center at Suburban Hospital
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. Dr. Dempsey is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education. He is active in physician...

1 news post(s)
Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Contract Research Organization, Independent/Small
  • Consultancy, Healthcare-Focused
  • Medical Device Manufacturer
  • Private/For-Profit Healthcare Research Entity
  • Research Foundation

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Owner
  • Director
  • Nurse - Clinical Educator
  • Physician - Director
  • President
  • Allied Health Professional
  • Chief Medical Officer
  • Operations Executive
  • Nurse Practitioner
  • Nurse - RN
  • Medical Director
  • Partner
  • Vice President
  • Physician - Division Head
  • Project Manager

Related Study Groups

Study Group Name No. Members
Niaspan Prescribers for Raising HDL 144
Fortamet Prescribers (US) 27
Physicians who Prescribe Sular in the U.S. 38
Byetta Prescribers for Diabetes 296
Byetta Prescribers for Diabetes: Endocrinologists (US) 141
Phentermine Prescribers for Obesity: Physicians (US) 51
Tricor Prescribers (US) 107
Byetta Prescribers for Diabetes: Endocrinologists 161

GLG Live Meetings with this Study Group's Leading Experts (?)

June 16, 2009 | New York

GLG Seminar: (NYC) Hot Topics from ADA 2009 with Kelly Close

June 15, 2009 | Boston

GLG Seminar: (BOS) Hot Topics from ADA 2009 with Kelly Close

June 4, 2009 | Palo Alto

GLG Seminar: (Palo Alto) Preview of 2009 ADA with Kelly Close

Webcast: Revised Revenue Opportunity - A Case Study of the Obesity Drug Market (12:00 PM EST)

1/18/2011

Play Recording